Death Penalty Removed From Federal Case Against Luigi Mangione

A federal judge has ruled that the death penalty will no longer be pursued against Luigi Mangione in connection with the killing of UnitedHealthcare executive Brian Thompson, after dismissing the most serious federal charges in the case.

The ruling significantly narrows the federal prosecution but does not end Mangione’s legal challenges, as he continues to face multiple cases at the state level.

Why the Death Penalty Was Dismissed

The decision focuses on federal charges linked to the December 4, 2024, shooting outside a Manhattan hotel. Prosecutors had accused Mangione of committing murder with a firearm during another federal crime, a charge that made him eligible for capital punishment.

In a written order issued on January 30, U.S. District Judge Margaret M. Garnett ruled that the underlying offenses did not meet the legal definition of a “crime of violence” under federal law.

As a result, the court dismissed both the firearm-related murder charge and a related weapons count, removing the death penalty as a sentencing option.

Federal Charges That Still Stand

Mangione will still face trial on two federal stalking charges. Prosecutors allege that those actions directly contributed to Thompson’s death.

If convicted, Mangione could still receive a sentence of life in prison without the possibility of parole.

Justice Department’s Earlier Position

In 2025, the U.S. Justice Department had instructed prosecutors to seek the death penalty in the case. Mangione’s defense team criticized that decision, arguing it was politically motivated.

The judge’s ruling effectively ends that effort in federal court.

State-Level Cases in New York and Pennsylvania

Separate from the federal proceedings, Mangione faces nine felony charges in New York, including second-degree murder, which carries a possible sentence of 25 years to life in prison.

A judge previously dismissed terrorism-related counts in the New York case, and no trial date has been scheduled.

Mangione is also charged in Pennsylvania with weapons-related offenses following his arrest after a multistate manhunt. He has pleaded not guilty.

Allegations and Public Reaction

Prosecutors allege Mangione shot Thompson from behind using a 3D-printed firearm. Court filings claim his personal writings showed hostility toward the health insurance industry.

While political leaders condemned the killing, the case has also drawn public support for Mangione, with supporters attending court hearings and donating to his legal defense.

What Comes Next

Although the federal case has narrowed, Mangione still faces significant legal risk across multiple jurisdictions. Court proceedings are expected to continue for months.